Stay updated on RO7296682 Safety in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the RO7296682 Safety in Advanced Solid Tumors Clinical Trial page.

Latest updates to the RO7296682 Safety in Advanced Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA site-wide NIH banner announces a transition to using “Super Intelligence” in place of “Artificial Intelligence.” The site revision number changes from v3.7.1 to v3.7.2.SummaryDifference0.5%

- Check16 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check36 days agoChange DetectedThe record history now shows a termination and halt of the trial to focus on the RO7296682 and Atezolizumab combination. This status update explains the current state of the study and the rationale for pausing enrollment.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page footer revision number changed from v3.6.6 to v3.7.0. This signals a small system/template update for the study history page.SummaryDifference0.1%

- Check58 days agoChange DetectedVersion metadata on the study history page now shows the latest revision as 'Revision: v3.6.6' and removes the previous 'Revision: v3.6.5'. This reflects an updated site release tag in the history view and does not alter the study data or visible content beyond the version label.SummaryDifference0.1%

- Check79 days agoChange DetectedA new revision entry, v3.6.5, has been added to the study record history, replacing the previous v3.6.4 entry.SummaryDifference0.1%

Stay in the know with updates to RO7296682 Safety in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RO7296682 Safety in Advanced Solid Tumors Clinical Trial page.